Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Base Year For Estimation | 2025 |
| Forecast Data Period | 2026 - 2031 |
| Historical Data Period | 2020 - 2024 |
| Market Size (2026) | USD 105.05 Million |
| Market Size (2031) | USD 175.64 Million |
| Growth Rate (2026 - 2031) | 10.83% CAGR |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Malaysia Diabetes Care Devices Market Analysis by Mordor Intelligence
The Malaysia Diabetes Care Devices Market size is estimated at USD 105.05 million in 2026, and is expected to reach USD 175.64 million by 2031, at a CAGR of 10.83% during the forecast period (2026-2031).
The Malaysian Ministry of Health announced that the Southeast Asian nation recorded 5,809 new COVID-19 cases in 24 hours, including 5,782 domestically infected and 27 imported ones. This brought the national tally to 2,541,147. About 78.4 percent of the Malaysian population received at least one vaccine against COVID-19, while 75.9 percent were fully vaccinated. Out of every 10 people who died from COVID-19 in Malaysia this year, about four had diabetes; the Health Ministry told Sunday Star. In Malaysia, one in five people lives with diabetes, which reaches about 3.9 million people aged 18 and above.
Young diabetics are on the rise. More younger people are getting diabetes, with patients aged between 18 and 40 doubling over the past 15 years. The rising number of people with diabetes means an increased burden of the disease and its complications: heart disease, stroke, blindness, chronic kidney disease, and lower limb amputation, among others. Most of the coronavirus deaths in Malaysia had underlying comorbidities, with diabetes and hypertension topping the list.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Malaysia Diabetes Care Devices Market Trends and Insights
Management Devices Hold Highest Market Share in Malaysia Diabetes Care Devices Market
Malaysia has the highest rate of diabetes in the Western Pacific region and one of the highest in the world, costing around 600 million US dollars annually. The rising trend is due to several factors, including population growth, population aging, urbanization, and rising obesity and physical inactivity rates. The rising incidence of diabetes and its consequences in Malaysia inspired this study to systematically identify, characterize, and estimate the pooled prevalence of diabetes and prediabetes in Malaysia.
Although the use of insulin pumps in the West has increased by leaps and bounds, especially among type 1 diabetic individuals, its use in Malaysia remains very limited. The basal insulin infusion, which substitutes the intermediate- or long-acting subcutaneous insulin injection, provides insulin continuously throughout the day at pre-set rates that are changed based on the individual's specific requirements.
A community initiative supported by AstraZeneca in partnership with the Malaysian Endocrine & Metabolic Society (MEMS), The first-ever survey took place online from 12 April until 9 May 2021, with the support of several pharmacies and media partners. The purpose of this inaugural survey is to obtain a baseline of Malaysia’s awareness level and also to identify key knowledge gaps. The insights from this year’s 2,539 responses (which have been stratified to represent the overall population) will shape how AstraZeneca and MEMS conceptualize public education initiatives in the year ahead.
Government initiatives are driving the market in the forecast period.
Increasing Diabetes Population in Malaysia
Because diabetes and prediabetes are rising in Malaysia, the Malaysian government implements diabetes prevention and control programs nationwide. The Malaysian government should establish a comprehensive approach and plan to improve diabetes knowledge, control, prevention, and treatment to reduce the prevalence of diabetes in the country. Being overweight and obese are key drivers of the younger diabetes population in Malaysia.
Recent NHMS found that one in two adults in Malaysia is overweight or obese. Those with diabetes have high levels of glucose or sugar in their blood. It’s a disease caused by the body not producing enough of the hormone insulin to control the amount of blood sugar. It can also be caused when the body doesn’t use insulin efficiently, also known as insulin resistance. Factors that drive this process include obesity, unhealthy eating habits, sedentary lifestyles, and genetics. In Malaysia, current statistics from the ministry’s National Diabetes Registry (NDR)show that 84% of patients with diabetes are overweight, and among them are young Malaysians aged 18 to 40.
The ministry is looking into an initiative known as the Sama-Sama program, which aims to empower family members and caregivers to support people living with diabetes to improve control and outcomes of the disease. “Under the program, the ministry is joining forces with the private sector to train healthcare providers and caregivers. The ministry is investigating the Sama-Sama program, which aims to empower family members and caregivers to support persons living with diabetes to enhance disease control and outcomes. The ministry collaborates with the commercial sector to train healthcare personnel on the program.
As a result, the diabetes care devices market in Malaysia is predicted to expand gradually in the coming years.
Competitive Landscape
The new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead in the race to create an artificial pancreas system rather than merely offering a boost to the continuous glucose monitoring devices market.
Malaysia Diabetes Care Devices Industry Leaders
Medtronic
Roche
NovoNordisk
Abbott
Dexcom
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- June 2023: Dexcom, a San Diego-based company specializing in continuous glucose monitors, has announced its intention to release a new wearable device in 2024. This device is specifically designed for individuals with Type 2 diabetes who do not require insulin, and is expected to contribute to the growing popularity of wearable health monitors.
- May 2023: Medtronic plc has recently disclosed its plans to acquire EOFlow Co. Ltd., a renowned manufacturer of the EOPatch device. This innovative insulin delivery device is tubeless, wearable, and fully disposable. By incorporating EOFlow into its portfolio, Medtronic aims to enhance its capacity to cater to a larger population of individuals with diabetes. This strategic move, coupled with Medtronic's advanced Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM), is anticipated to significantly broaden the company's capabilities in meeting the diverse requirements of people living with diabetes.
Malaysia Diabetes Care Devices Market Report Scope
There are two primary categories of devices used to measure blood glucose levels. The first type is comprised of blood glucose meters, which require a small sample of blood to determine your current levels. On the other hand, continuous glucose monitors (CGMs) are capable of regularly monitoring your blood glucose throughout the day and night. The Malaysia Diabetes Care Devices Market is segmented into devices. The report offers the market size in value terms in USD and Volume terms in Units for all the abovementioned segments.
Monitoring Devices
| Self-monitoring Blood Glucose Devices | Glucometer Devices |
| Test Strips | |
| Lancets | |
| Continuous Blood Glucose Monitoring | Sensors |
| Durables |
Management Devices
| Insulin Pump | Insulin Pump Device |
| Insulin Pump Reservoir | |
| Infusion Set | |
| Insulin Syringes | |
| Insulin Cartridges | |
| Disposable Pens |
| Monitoring Devices | Self-monitoring Blood Glucose Devices | Glucometer Devices |
| Test Strips | ||
| Lancets | ||
| Continuous Blood Glucose Monitoring | Sensors | |
| Durables | ||
| Management Devices | Insulin Pump | Insulin Pump Device |
| Insulin Pump Reservoir | ||
| Infusion Set | ||
| Insulin Syringes | ||
| Insulin Cartridges | ||
| Disposable Pens | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the Malaysia Diabetes Care Devices Market?
The Malaysia Diabetes Care Devices Market size is expected to reach USD 105.05 million in 2026 and grow at a CAGR of 10.83% to reach USD 175.64 million by 2031.
What is the current Malaysia Diabetes Care Devices Market size?
In 2025, the Malaysia Diabetes Care Devices Market size is expected to reach USD 95.24 million.
Who are the key players in Malaysia Diabetes Care Devices Market?
Medtronic, Roche, NovoNordisk, Abbott and Dexcom are the major companies operating in the Malaysia Diabetes Care Devices Market.
What years does this Malaysia Diabetes Care Devices Market cover, and what was the market size in 2024?
In 2024, the Malaysia Diabetes Care Devices Market size was estimated at USD 86.40 million. The report covers the Malaysia Diabetes Care Devices Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Malaysia Diabetes Care Devices Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
